Top Markets
Coin of the day
EyePoint Pharmaceuticals, Inc. EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc.

EYPT
อันดับในหุ้น #15070
EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the... EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the creation and marketing of ophthalmic solutions for various eye ailments. Its operations span the United States, China, and the United Kingdom. Among its commercialized product portfolio are ILUVIEN, an injectable, sustained-release micro-insert designed to treat diabetic macular edema, and YUTIQ, an intravitreal implant containing fluocinolone acetonide, which targets chronic non-infectious uveitis impacting the posterior segment of the eye. The company also offers DEXYCU, a dexamethasone intraocular suspension, utilized to manage post-operative ocular inflammation, such as that occurring after cataract surgery. Looking ahead, EyePoint is actively developing several pipeline therapies. This includes EYP-1901, a novel, bioerodible tyrosine kinase inhibitor currently formulated for twice-yearly administration, which is under development for conditions like wet age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion. Additionally, YUTIQ50 is being advanced as a treatment for chronic non-infectious uveitis affecting the posterior region of the eye. To bolster its market reach and development efforts, the company maintains strategic alliances with entities such as Alimera Sciences, Inc., Bausch & Lomb, OncoSil Medical UK Limited, Ocumension Therapeutics, and Equinox Science, LLC. Furthermore, a commercial collaboration with ImprimisRx PA, Inc. specifically focuses on the joint promotion of DEXYCU for inflammation following ocular surgery. Incorporated in 1987, the organization was previously known as pSivida Corp. before officially rebranding as EyePoint Pharmaceuticals, Inc. in March 2018. Its corporate headquarters are situated in Watertown, Massachusetts.
ราคาหุ้น
$4.48
ซิงค์ล่าสุด: 2026-08-31
มูลค่าตลาด
$375.37M
การเปลี่ยนแปลง (1 วัน)
-0.06%
การเปลี่ยนแปลง (1 ปี)
-61.30%
ประเทศ
US
ซื้อขาย EyePoint Pharmaceuticals, Inc. (EYPT)

หมวดหมู่

ประวัติราคาหุ้นของ EyePoint Pharmaceuticals, Inc. (EYPT)
ราคาปิดสูงสุด: $8.36 เมื่อ 2026-08-01

ราคาปิดต่ำสุด: $379.87 เมื่อ 2005-01-01
ประวัติราคาหุ้นของ EyePoint Pharmaceuticals, Inc. ตั้งแต่ 2005 ถึง 2026
ผลการดำเนินงานราคาหุ้นรายปี
ปี ประสิทธิภาพ
2026 (TTM) -19.87%
2025 116.50%
2024 -60.60%
2023 566.15%
2022 -78.68%
2021 183.07%
2020 -66.89%
2019 -27.25%
2018 80.00%
2017 -34.90%
2016 -56.63%
2015 -4.94%
2014 30.94%
2013 151.21%
2012 5.04%
2011 -78.05%
2010 47.76%
2009 269.05%
2008 -68.77%
2007 -56.96%
2006 -61.72%
2005 0.00%
ราคาหุ้นของบริษัทที่คล้ายกันหรือคู่แข่ง
บริษัท ราคาหุ้น การเปลี่ยนแปลง 1ปี% ประเทศ
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$747.82 4.81%
CH